Key result
Southern and Appalachian states are linked to higher inflammatory biomarkers among healthy women.
Cross-Sectional (n=26,029)
Yes
Significant geographic variation in cardiovascular inflammatory biomarkers exists among healthy US women, independent of traditional risk factors, with the highest levels in Southern and Appalachian states.
Answers are grounded in this paper and cite their sources.
Regional inflammation patterns may underlie CVD disparities; hypothesis-generating and should not yet change practice.
BACKGROUND: Geographic variation in traditional cardiovascular disease (CVD) risk factors has been observed among women in the US. It is not known whether state-level variation in cardiovascular inflammation exists or could be explained by traditional clinical risk factors and behavioral lifestyle factors. METHODS AND RESULTS: We used multilevel linear regression to estimate state-level variation in inflammatory biomarker patterns adjusted for clinical and lifestyle characteristics among 26,029 women free of CVD. Participants derived from the Women's Health Study, a national cohort of healthy middle-aged and older women. Inflammatory biomarker patterns (plasma levels of high-sensitivity C-reactive protein (hsCRP), soluble intercellular adhesion molecule-1 (sICAM-1), and fibrinogen) were compared to state-level patterns of traditional CVD risk factors and global risk scores. We found that all three inflammatory biomarkers exhibited significant state-level variation including hsCRP (lowest vs. highest state median 1.3 mg/L vs. 2.7 mg/L, unadjusted random effect estimate 1(st) to 99(th) percentile range for log hsCRP 0.52, p<.001), sICAM-1 (325 ng/ml vs. 366ng/ml, unadjusted random effect estimate 1(st) to 99(th) percentile range 0.44, p<.001), and fibrinogen (322 mg/dL vs. 367 mg/dL, unadjusted random effect estimate 1(st) to 99(th) percentile range 0.41, p = .001). Neither demographic, clinical or lifestyle characteristics explained away state-level effects in biomarker patterns. Southern and Appalachian states (Arkansas, West Virginia) had the highest inflammatory biomarker values. Regional geographic patterns of traditional CVD risk factors and risk scores did not completely overlap with biomarkers of inflammation. CONCLUSIONS: There is state-level geographic variation in inflammatory biomarkers among otherwise healthy women that cannot be completely attributed to traditional clinical risk factors or lifestyle characteristics. Future research should aim to identify additional factors that may explain geographic variation in biomarkers of inflammation among healthy women.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2011) conducted a cross-sectional in Healthy (free of cardiovascular disease and cancer) (n=26,029). Geographic location (State of residence) vs. Other states was evaluated on State-level variation in log hsCRP (random effect estimate 0.52, p=<0.001). Geographic location was associated with significant state-level variation in inflammatory biomarkers among healthy women, with the highest levels in Southern and Appalachian states, independent of traditional clinical and lifestyle risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: